| |
|
|
|
|
| Slide Lecture Programs |
| 2006 Core Curriculum |
| Contemporary Management of Myocardial Ischemia |
May 17, 2006
|
| V: |
New Therapeutic Options for Chronic Stable Angina |
Slide 60 |
|
Download PowerPoint
|
CARISA: Ranolazine increases exercise duration
- Ranolazine SR doses of 750 mg bid and 1000 mg bid significantly increased exercise duration at trough (data shown) and peak (data not shown) compared with placebo.
- Exercise duration at trough was similar for both doses of ranolazine compared with placebo. Improved exercise duration persisted throughout the 12-week period.
- Benefit was additive to background therapy with traditional antianginals.
|
|
|
Resources
